<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03910686</url>
  </required_header>
  <id_info>
    <org_study_id>2019-12-TMSCBT</org_study_id>
    <nct_id>NCT03910686</nct_id>
  </id_info>
  <brief_title>Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Alcohol Dependence</brief_title>
  <acronym>TAD</acronym>
  <official_title>Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Alcohol Dependence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alcohol dependence is one of most common substance dependence, which brings great burden on
      health worldwide. Alcohol dependence may lead to many serious diseases or consequences
      including cancer, cardiovascular diseases and accidents. Once alcohol dependence is
      developed, it will be difficult to recover and easy to relapse. Although many efforts had
      been made in the treatment of alcohol dependence, the annual recurrence of alcohol dependence
      with traditional therapies was over 45%. Repetitive transcranial magnetic stimulation (rTMS)
      on the dorsolateral prefrontal cortex (DLPFC) or cognitive behavioral therapy (CBT) each
      alone was reported to have some effect on preventing from relapse of alcohol dependence. In
      order to test whether combined therapy of high frequency rTMS (hf-rTMS) with CBT is better
      for preventing from relapse of alcohol dependence, we recruit patients with alcohol
      dependence to participate this study. The study is a factorial designed and the patients will
      be assigned into one of the following six groups randomly: (1) regular treatment (symptomatic
      treatment) with blank TMS; (2) regular treatment (RT) with blank TMS and CBT; (3) RT with
      right DLPFC hf-rTMS; (4) RT with right DLPFC hf-rTMS and CBT; (5) RT with left DLPFC hf-rTMS;
      (6) RT with left DLPFC hf-rTMS and CBT. TMS was given 5 days per week for total 2 weeks using
      uniform scheme (5 seconds of 10Hz stimulation per train, 30 trains per day with inter-train
      interval of 20 seconds). CBT will be given once per week for total 8 weeks. The patients will
      be followed up for 6 months. Recurrence of alcohol dependence, duration of abstention,
      alcohol intake, craving for alcohol and other cognitive psychological assessments will be
      recorded and compared among the 6 treatment groups and the efficacy of combined therapy of
      rTMS with CBT will be evaluated in our study.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The rate of relapse of alcohol dependence after discharge from hospital</measure>
    <time_frame>1 month</time_frame>
    <description>Recurrence of alcohol dependence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The rate of relapse of alcohol dependence after discharge from hospital</measure>
    <time_frame>2 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The rate of relapse of alcohol dependence after discharge from hospital</measure>
    <time_frame>3 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The rate of relapse of alcohol dependence after discharge from hospital</measure>
    <time_frame>6 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of abstinence</measure>
    <time_frame>6 months</time_frame>
    <description>The total time or period without any intake of alcohol during follow ups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol intake</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Diaries of alcohol intake in different time of the follow ups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Craving for alcohol</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Craving assessment for alcohol by Obsessive Compulsive Drinking Scale (OCDS) ranging from 0 to 40. Higher score of OCDS indicates more desire for alcohol.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Craving for alcohol</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Craving assessment by Visual Analogue Scale (VAS) for alcohol desire ranging from 0 to 10. Higher score indicates more desire for alcohol.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive assessment</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Cognitive assessment by Montreal Cognitive Assessment (MoCA) ranging from 0 to 30. Lower score indicates worse cognitive function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological assessment - Anxiety</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Psychological assessment by Generalized Anxiety Disorder-7 (GAD-7) ranging from 0 to 21. Higher score indicates more severer anxiety.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological assessment - Depression</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Psychological assessment by Patient Health Questionnaire-9 (PHQ-9) ranging from 0 to 27. Higher score indicates more severer depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological assessment - Sleep</measure>
    <time_frame>2 weeks, 1 month, 2 months, 3 months and 6 months</time_frame>
    <description>Psychological assessment by Pittsburgh Sleep Quality Index (PSQI) ranging from 0 to 21. Higher score indicates worse sleep.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Alcohol Dependence</condition>
  <arm_group>
    <arm_group_label>Regular treatment (symptomatic treatment) with blank TMS</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Regular treatment (symptomatic treatment) with blank transcranial magnetic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regular treatment (RT) with blank TMS and CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment (symptomatic treatment) with blank transcranial magnetic stimulation and cognitive behavioral therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RT with right DLPFC hf-rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment with right dorsolateral prefrontal cortex (DLPFC) high frequency repetitive transcranial magnetic stimulation (hf-rTMS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RT with right DLPFC hf-rTMS and CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment with right DLPFC high frequency repetitive transcranial magnetic stimulation (hf-rTMS) and cognitive behavioral therapy (CBT)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RT with left DLPFC hf-rTMS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment with left DLPFC high frequency repetitive transcranial magnetic stimulation (hf-rTMS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RT with left DLPFC hf-rTMS and CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Regular treatment with left DLPFC high frequency repetitive transcranial magnetic stimulation (hf-rTMS) and cognitive behavioral therapy (CBT)</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Transcranial magnetic stimulation and cognitive behavioral therapy</intervention_name>
    <description>Transcranial magnetic stimulation on different side with/without cognitive behavioral therapy</description>
    <arm_group_label>RT with left DLPFC hf-rTMS</arm_group_label>
    <arm_group_label>RT with left DLPFC hf-rTMS and CBT</arm_group_label>
    <arm_group_label>RT with right DLPFC hf-rTMS</arm_group_label>
    <arm_group_label>RT with right DLPFC hf-rTMS and CBT</arm_group_label>
    <arm_group_label>Regular treatment (RT) with blank TMS and CBT</arm_group_label>
    <arm_group_label>Regular treatment (symptomatic treatment) with blank TMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis as alcohol dependence according to DSM-IV criteria

          -  No definite history of neurological diseases and psychological problems

          -  Volunteer to participate the study, cooperate to be followed up

        Exclusion Criteria:

          -  Acute withdrawal state and CIWA score &gt; 9

          -  With other neurological diseases and psychological problems

          -  With ever brain trauma and damage

          -  With other psychological medications or other substance dependence

          -  With other contraindications to have transcranial magnetic stimulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ying Peng, MD, PhD</last_name>
    <phone>+86-13380051581</phone>
    <email>pengy2@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hongxuan Wang, MD, PhD</last_name>
    <phone>+86-13824498978</phone>
    <email>wanghx8@mail.sysu.edu.cn</email>
  </overall_contact_backup>
  <reference>
    <citation>Phillips MR, Zhang J, Shi Q, Song Z, Ding Z, Pang S, Li X, Zhang Y, Wang Z. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet. 2009 Jun 13;373(9680):2041-53. doi: 10.1016/S0140-6736(09)60660-7.</citation>
    <PMID>19524780</PMID>
  </reference>
  <reference>
    <citation>Tang YL, Hao W, Leggio L. Treatments for alcohol-related disorders in China: a developing story. Alcohol Alcohol. 2012 Sep-Oct;47(5):563-70. doi: 10.1093/alcalc/ags066. Epub 2012 Jun 7. Review.</citation>
    <PMID>22683652</PMID>
  </reference>
  <reference>
    <citation>Mishra BR, Nizamie SH, Das B, Praharaj SK. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham-controlled study. Addiction. 2010 Jan;105(1):49-55. doi: 10.1111/j.1360-0443.2009.02777.x.</citation>
    <PMID>20078462</PMID>
  </reference>
  <reference>
    <citation>Herremans SC, Vanderhasselt MA, De Raedt R, Baeken C. Reduced intra-individual reaction time variability during a Go-NoGo task in detoxified alcohol-dependent patients after one right-sided dorsolateral prefrontal HF-rTMS session. Alcohol Alcohol. 2013 Sep-Oct;48(5):552-7. doi: 10.1093/alcalc/agt054. Epub 2013 May 24.</citation>
    <PMID>23709633</PMID>
  </reference>
  <reference>
    <citation>Mishra BR, Praharaj SK, Katshu MZ, Sarkar S, Nizamie SH. Comparison of anticraving efficacy of right and left repetitive transcranial magnetic stimulation in alcohol dependence: a randomized double-blind study. J Neuropsychiatry Clin Neurosci. 2015 Winter;27(1):e54-9. doi: 10.1176/appi.neuropsych.13010013.</citation>
    <PMID>25255169</PMID>
  </reference>
  <reference>
    <citation>Herremans SC, De Raedt R, Van Schuerbeek P, Marinazzo D, Matthys F, De Mey J, Baeken C. Accelerated HF-rTMS Protocol has a Rate-Dependent Effect on dACC Activation in Alcohol-Dependent Patients: An Open-Label Feasibility Study. Alcohol Clin Exp Res. 2016 Jan;40(1):196-205. doi: 10.1111/acer.12937.</citation>
    <PMID>26727534</PMID>
  </reference>
  <reference>
    <citation>Sundström C, Kraepelien M, Eék N, Fahlke C, Kaldo V, Berman AH. High-intensity therapist-guided internet-based cognitive behavior therapy for alcohol use disorder: a pilot study. BMC Psychiatry. 2017 May 26;17(1):197. doi: 10.1186/s12888-017-1355-6.</citation>
    <PMID>28549424</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 10, 2019</study_first_posted>
  <last_update_submitted>April 12, 2019</last_update_submitted>
  <last_update_submitted_qc>April 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Ying Peng</investigator_full_name>
    <investigator_title>Professor, Director of Department of Neurology</investigator_title>
  </responsible_party>
  <keyword>Alcohol Dependence, transcranial magnetic stimulation, cognitive behavioral therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

